NEW YORK (GenomeWeb News) – Strand Genomics and BioHealth Innovation today announced a strategic partnership to expand the Strand Centers for Genomics and Personalized Medicine into the US.

As part of the deal, BHI will connect Strand with "key" market channels, providing patients and healthcare providers with access to genomic services. Based in Rockville, Md., BHI describes itself as an "innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.